First Case of Ovarian Metastases From a Primary Retroperitoneal Mucinous Carcinoma Associated With Teratoma, With KRAS and ERBB3 Mutations: Case Report and Literature Review.
AuteursFallas J, Salmon I, Maris C, Gómez Galdón M, D'Haene N, Noël JC, Catteau X
Current State-Of-Play of the EU Advanced Therapy Medicinal Product (ATMP) Field, With an Emphasis on Belgian Human Cell and Tissue Products.
AuteursVerbeken G, Convents L, Delmotte N, Draye JP, Jennes S, Vanderkelen A, Nijs G, Lewalle P, Baudoux E, Cornu O, Vanlaere I, Pierlot A, Rose T, Pirnay JP
Histopathological insights into metastatic breast cancer gained from rapid autopsies.
AuteursZels G, Pabba A, De Schepper M, Geukens T, Van Baelen K, Maetens M, Mahdami A, Leduc S, Isnaldi E, Nguyen HL, Bachir I, Van Cauwenberge J, Borremans K, Weynand B, Biganzoli E, Neven P, Wildiers H, Van Den Bogaert W, Richard F, Desmedt C, Floris G
The association of high body mass index with the safety and efficacy of sacituzumab govitecan in patients with metastatic triple-negative breast cancer from the ASCENT study.
AuteursGarcía-Estévez L, Bardia A, Rugo HS, Carey LA, Diéras VC, Loibl S, Piccart M, Gianni L, Kalinsky K, O'Shaughnessy J, Hurvitz SA, Harting E, Valdez T, Phan S, Lai C, Cortés J
Association of HER2-low with clinicopathological features in patients with early invasive lobular breast cancer: an international multicentric study.
AuteursVan Baelen K, Nguyen HL, Richard F, Zels G, Karsten MM, Nader-Marta G, Vermeulen P, Dirix L, Dordevic AD, de Azambuja E, Larsimont D, Maetens M, Biganzoli E, Wildiers H, Smeets A, Nevelsteen I, Neven P, Floris G, Desmedt C
Association of HER2-low with clinicopathological features in patients with early invasive lobular breast cancer: an international multicentric study.
AuteursVan Baelen K, Nguyen HL, Richard F, Zels G, Karsten MM, Nader-Marta G, Vermeulen P, Dirix L, Dordevic AD, de Azambuja E, Larsimont D, Maetens M, Biganzoli E, Wildiers H, Smeets A, Nevelsteen I, Neven P, Floris G, Desmedt C
